It was found that patients with GD and heterozygous carriers carrying mutations in the GBA gene developed PD at a higher frequency than the control population, suggesting that mutations in the GBA gene may be involved in the pathogenesis of PD. This evidence concerns the gene GBA1 and Parkinson disease.